Literature DB >> 1231566

The relationship of actin and myosin filaments within myocardial zonal lesions.

S W Unger, N B Ratliff.   

Abstract

Cross sections, including serial sections, of myocardial zonal lesions in right vetricular papillary muscles of cats subjected to hypovolemic shock were examined by electron microscopy. It was determined that the basic structure of A and I bands was retained even in severe zonal lesions with herniation of A and I bands through the intercalated disc into adjacent myocytes. The herniated A and I bands, together with accompanying mitochondria, were enclosed in membranes, apparently the unspecialized portion of the intercalated disc. Since the longitudinal orientation of myofilaments is retained in zonal lesions, this study indicates that intact A and I bands must slide past one another during the supercontraction of sarcomeres which is characteristic of zonal lesions. This study also presents evidence that the nexus may become involved in zonal lesions.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1231566      PMCID: PMC1913014     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  17 in total

1.  Letter to the editors: Myocardial zonal lesions and myofibrillar degeneration: the need for definition.

Authors:  N B Ratliff
Journal:  J Mol Cell Cardiol       Date:  1975-03       Impact factor: 5.000

2.  THE ULTRASTRUCTURE OF ZONAL LESIONS OF THE MYOCARDIUM IN HEMORRHAGIC SHOCK.

Authors:  A M MARTIN; D B HACKEL; S M KURTZ
Journal:  Am J Pathol       Date:  1964-01       Impact factor: 4.307

3.  FUNCTIONAL CARDIAC DETERIORATION DURING DEVELOPMENT OF HEMORRHAGIC CIRCULATORY DEFICIENCY.

Authors:  O A GOMEZ; W F HAMILTON
Journal:  Circ Res       Date:  1964-04       Impact factor: 17.367

4.  Effects of hemorrhagic shock on the heart and circulation of intact dogs.

Authors:  D B HACKEL; W T GOODALE
Journal:  Circulation       Date:  1955-04       Impact factor: 29.690

5.  Further evidence favoring a cardiac mechanism in irreversible hemorrhagic shock.

Authors:  J W CROWELL; A C GUYTON
Journal:  Am J Physiol       Date:  1962-08

6.  Light and electron microscopic observations of the myocardium of dogs in hemorrhagic shock.

Authors:  H Kajihara; H Hara; S Seyama; S Iijima; M Yoshidoa
Journal:  Acta Pathol Jpn       Date:  1973-05

7.  Myocardial oxygen metabolism and myocardial blood flow in dogs in hemorrhagic shock.

Authors:  N B Ratliff; D B Hackel; E Mikat
Journal:  Circ Res       Date:  1969-06       Impact factor: 17.367

8.  Ultrastructral effects of in virto experimentation on right ventricular papillary muscle from cats in hypovolemic shock (38487).

Authors:  R D Goldner; N B Ratliff; R I Kopelman; D B Hackel
Journal:  Proc Soc Exp Biol Med       Date:  1975-01

9.  Corticosteroid antagonism of the positive inotropic effect of ouabain.

Authors:  A M Lefer
Journal:  J Pharmacol Exp Ther       Date:  1966-02       Impact factor: 4.030

10.  Fixation by means of glutaraldehyde-hydrogen peroxide reaction products.

Authors:  C Peracchia; B S Mittler
Journal:  J Cell Biol       Date:  1972-04       Impact factor: 10.539

View more
  4 in total

1.  Effect of angiotensin-induced hypertension on rat coronary arteries and myocardium.

Authors:  F Giacomelli; P Anversa; J Wiener
Journal:  Am J Pathol       Date:  1976-07       Impact factor: 4.307

2.  Myocardial lesions in hemorrhagic hypotension.

Authors:  T Varga; A Réffy; E Vándor
Journal:  Z Rechtsmed       Date:  1980-01

3.  [Ultrastructural morphometric analysis of normally loaded human myocardial left ventricles from young and old patients (author's transl)].

Authors:  M Fleischer; H Warmuth; K P Backwinkel; H Themann
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1978-10-26

4.  Abnormal myocardial fluid retention as an early manifestation of ischemic injury.

Authors:  J T Willerson; F Scales; A Mukherjee; M Platt; G H Templeton; G S Fink; L M Buja
Journal:  Am J Pathol       Date:  1977-04       Impact factor: 4.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.